Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Clinical characteristics and outcomes of methamphetamine-associated intracerebral hemorrhage.

Swor DE, Maas MB, Walia SS, Bissig DP, Liotta EM, Naidech AM, Ng KL.

Neurology. 2019 Jul 2;93(1):e1-e7. doi: 10.1212/WNL.0000000000007666. Epub 2019 May 29.

PMID:
31142634
2.

Admission Heart Rate Variability is Associated with Fever Development in Patients with Intracerebral Hemorrhage.

Swor DE, Thomas LF, Maas MB, Grimaldi D, Manno EM, Sorond FA, Batra A, Kim M, Prabhakaran S, Naidech AM, Liotta EM.

Neurocrit Care. 2019 Apr;30(2):244-250. doi: 10.1007/s12028-019-00684-w.

PMID:
30756320
3.

Depressive symptom prevalence after intracerebral hemorrhage: a multi-center study.

Francis BA, Beaumont J, Maas MB, Liotta EM, Cella D, Prabhakaran S, Holl J, Kho A, Naidech AM.

J Patient Rep Outcomes. 2018 Nov 23;2(1):55. doi: 10.1186/s41687-018-0083-0.

4.

Assessment and comparison of the max-ICH score and ICH score by external validation.

Schmidt FA, Liotta EM, Prabhakaran S, Naidech AM, Maas MB.

Neurology. 2018 Sep 4;91(10):e939-e946. doi: 10.1212/WNL.0000000000006117. Epub 2018 Aug 1.

5.

Prophylactic Seizure Medication and Health-Related Quality of Life After Intracerebral Hemorrhage.

Naidech AM, Beaumont J, Muldoon K, Liotta EM, Maas MB, Potts MB, Jahromi BS, Cella D, Prabhakaran S, Holl JL.

Crit Care Med. 2018 Sep;46(9):1480-1485. doi: 10.1097/CCM.0000000000003272.

6.

The authors reply.

Liotta EM, Ganger D, Ladner DP, Maas MB.

Crit Care Med. 2018 Jul;46(7):e728-e729. doi: 10.1097/CCM.0000000000003180. No abstract available.

7.

Author response: Magnesium, hemostasis, and outcomes in patients with intracerebral hemorrhage.

Liotta EM, Prabhakaran S, Maas MB.

Neurology. 2018 Apr 3;90(14):667. doi: 10.1212/WNL.0000000000005272. No abstract available.

PMID:
29610232
8.

Fever Burden and Health-Related Quality of Life After Intracerebral Hemorrhage.

Bush RA, Beaumont JL, Liotta EM, Maas MB, Naidech AM.

Neurocrit Care. 2018 Oct;29(2):189-194. doi: 10.1007/s12028-018-0523-y.

PMID:
29600341
9.

Osmotic Shifts, Cerebral Edema, and Neurologic Deterioration in Severe Hepatic Encephalopathy.

Liotta EM, Romanova AL, Lizza BD, Rasmussen-Torvik LJ, Kim M, Francis B, Sangha RS, Carroll TJ, Ganger D, Ladner DP, Naidech AM, Paparello JJ, Prabhakaran S, Sorond FA, Maas MB.

Crit Care Med. 2018 Feb;46(2):280-289. doi: 10.1097/CCM.0000000000002831.

10.

Medication History versus Point-of-Care Platelet Activity Testing in Patients with Intracerebral Hemorrhage.

Maas MB, Naidech AM, Kim M, Batra A, Manno EM, Sorond FA, Prabhakaran S, Liotta EM.

J Stroke Cerebrovasc Dis. 2018 May;27(5):1167-1173. doi: 10.1016/j.jstrokecerebrovasdis.2017.11.033. Epub 2018 Jan 5.

11.

Incidence and Risk Factors of Intracranial Hemorrhage in Liver Transplant Recipients.

Gallagher TK, Thomas KA, Ladner DP, Ganger D, Sorond FA, Prabhakaran S, Abecassis MM, Fryer JP, Liotta EM.

Transplantation. 2018 Mar;102(3):448-453. doi: 10.1097/TP.0000000000002005.

12.

Magnesium, hemostasis, and outcomes in patients with intracerebral hemorrhage.

Liotta EM, Prabhakaran S, Sangha RS, Bush RA, Long AE, Trevick SA, Potts MB, Jahromi BS, Kim M, Manno EM, Sorond FA, Naidech AM, Maas MB.

Neurology. 2017 Aug 22;89(8):813-819. doi: 10.1212/WNL.0000000000004249. Epub 2017 Jul 26.

13.

Refining Prognosis for Intracerebral Hemorrhage by Early Reassessment.

Maas MB, Francis BA, Sangha RS, Lizza BD, Liotta EM, Naidech AM.

Cerebrovasc Dis. 2017;43(3-4):110-116. doi: 10.1159/000452679. Epub 2017 Jan 4.

14.

Agitation, Delirium, and Cognitive Outcomes in Intracerebral Hemorrhage.

Rosenthal LJ, Francis BA, Beaumont JL, Cella D, Berman MD, Maas MB, Liotta EM, Askew R, Naidech AM.

Psychosomatics. 2017 Jan - Feb;58(1):19-27. doi: 10.1016/j.psym.2016.07.004. Epub 2016 Aug 5.

15.

Diagnostic Yield of Universal Urine Toxicology Screening in an Unselected Cohort of Stroke Patients.

Kalani R, Liotta EM, Prabhakaran S.

PLoS One. 2015 Dec 16;10(12):e0144772. doi: 10.1371/journal.pone.0144772. eCollection 2015.

16.

23.4% Saline Decreases Brain Tissue Volume in Severe Hepatic Encephalopathy as Assessed by a Quantitative CT Marker.

Liotta EM, Lizza BD, Romanova AL, Guth JC, Berman MD, Carroll TJ, Francis B, Ganger D, Ladner DP, Maas MB, Naidech AM.

Crit Care Med. 2016 Jan;44(1):171-9. doi: 10.1097/CCM.0000000000001276.

17.

Neurochecks as a Biomarker of the Temporal Profile and Clinical Impact of Neurologic Changes after Intracerebral Hemorrhage.

Maas MB, Berman MD, Guth JC, Liotta EM, Prabhakaran S, Naidech AM.

J Stroke Cerebrovasc Dis. 2015 Sep;24(9):2026-31. doi: 10.1016/j.jstrokecerebrovasdis.2015.04.045. Epub 2015 Jul 2.

18.

Do efforts to decrease door-to-needle time risk increasing stroke mimic treatment rates?

Liberman AL, Liotta EM, Caprio FZ, Ruff I, Maas MB, Bernstein RA, Khare R, Bergman D, Prabhakaran S.

Neurol Clin Pract. 2015 Jun;5(3):247-252.

19.

Reversal of the novel oral anticoagulants dabigatran, rivoraxaban, and apixaban.

Liotta EM, Levasseur-Franklin KE, Naidech AM.

Curr Opin Crit Care. 2015 Apr;21(2):127-33. doi: 10.1097/MCC.0000000000000181. Review.

PMID:
25689124
20.

Acute changes in ventricular volume during treatment for hepatic and renal failure.

Liotta EM, Bauer RM, Berman MD, Guth JC, Maas MB, Naidech AM, Rosenberg NF.

Neurol Clin Pract. 2014 Dec;4(6):478-481. No abstract available.

21.

Subarachnoid extension of hemorrhage is associated with early seizures in primary intracerebral hemorrhage.

Guth JC, Gerard EE, Nemeth AJ, Liotta EM, Prabhakaran S, Naidech AM, Maas MB.

J Stroke Cerebrovasc Dis. 2014 Nov-Dec;23(10):2809-13. doi: 10.1016/j.jstrokecerebrovasdis.2014.07.023. Epub 2014 Sep 4.

PMID:
25194742
22.

Magnetic resonance imaging versus computed tomography for identification and quantification of intraventricular hemorrhage.

Romanova AL, Nemeth AJ, Berman MD, Guth JC, Liotta EM, Naidech AM, Maas MB.

J Stroke Cerebrovasc Dis. 2014 Sep;23(8):2036-2040. doi: 10.1016/j.jstrokecerebrovasdis.2014.03.005. Epub 2014 Jul 30.

23.

Desmopressin improves platelet activity in acute intracerebral hemorrhage.

Naidech AM, Maas MB, Levasseur-Franklin KE, Liotta EM, Guth JC, Berman M, Rosenow JM, Lindholm PF, Bendok BR, Prabhakaran S, Bernstein RA, Kwaan HC.

Stroke. 2014 Aug;45(8):2451-3. doi: 10.1161/STROKEAHA.114.006061. Epub 2014 Jul 8.

24.

Pearls & oy-sters: bilateral thalamic involvement in West Nile virus encephalitis.

Guth JC, Futterer SA, Hijaz TA, Liotta EM, Rosenberg NF, Naidech AM, Maas MB.

Neurology. 2014 Jul 8;83(2):e16-7. doi: 10.1212/WNL.0000000000000571. No abstract available.

25.

Subarachnoid extension of primary intracerebral hemorrhage is associated with fevers.

Guth JC, Nemeth AJ, Rosenberg NF, Kosteva AR, Bauer RM, Liotta EM, Prabhakaran S, Naidech AM, Maas MB.

Neurocrit Care. 2014 Apr;20(2):187-92. doi: 10.1007/s12028-013-9888-0.

PMID:
24186539
26.

Predictors of 30-day readmission after intracerebral hemorrhage: a single-center approach for identifying potentially modifiable associations with readmission.

Liotta EM, Singh M, Kosteva AR, Beaumont JL, Guth JC, Bauer RM, Prabhakaran S, Rosenberg NF, Maas MB, Naidech AM.

Crit Care Med. 2013 Dec;41(12):2762-9. doi: 10.1097/CCM.0b013e318298a10f.

27.

Surveillance neuroimaging and neurologic examinations affect care for intracerebral hemorrhage.

Maas MB, Rosenberg NF, Kosteva AR, Bauer RM, Guth JC, Liotta EM, Prabhakaran S, Naidech AM.

Neurology. 2013 Jul 9;81(2):107-12. doi: 10.1212/WNL.0b013e31829a33e4. Epub 2013 Jun 5.

28.

Subarachnoid extension of primary intracerebral hemorrhage is associated with poor outcomes.

Maas MB, Nemeth AJ, Rosenberg NF, Kosteva AR, Guth JC, Liotta EM, Prabhakaran S, Naidech AM.

Stroke. 2013 Mar;44(3):653-7. doi: 10.1161/STROKEAHA.112.674341. Epub 2013 Feb 7.

PMID:
23391854
29.

Warfarin-associated intracerebral hemorrhage is increasing in prevalence in the United States.

Liotta EM, Prabhakaran S.

J Stroke Cerebrovasc Dis. 2013 Oct;22(7):1151-5. doi: 10.1016/j.jstrokecerebrovasdis.2012.11.015. Epub 2013 Jan 1.

PMID:
23287421
30.

Re: Confounding by indication in retrospective studies of intracerebral hemorrhage: antiepileptic treatment and mortality.

Naidech AM, Maas MB, Liotta EM, Guth JC, Bauer RM, Garg RK, Schuele SU, Bleck TP.

Neurocrit Care. 2013 Apr;18(2):285-6. doi: 10.1007/s12028-012-9811-0. No abstract available.

PMID:
23283600
31.

Erdheim-Chester disease.

Liotta EM, Jhaveri MD, Fox JC, Parameswaran V, Lewis SL.

Arch Neurol. 2012 Nov;69(11):1514-5. No abstract available.

PMID:
22925950
32.

Warfarin-associated intracerebral hemorrhage is inadequately treated at community emergency departments.

Liotta EM, Garg RK, Temes RE, John S, Lee VH, Bleck TP, Prabhakaran S.

Stroke. 2012 Sep;43(9):2503-5. doi: 10.1161/STROKEAHA.112.664540. Epub 2012 Jul 5.

PMID:
22773555
33.

Engineered conformation-dependent VEGF peptide mimics are effective in inhibiting VEGF signaling pathways.

Vicari D, Foy KC, Liotta EM, Kaumaya PT.

J Biol Chem. 2011 Apr 15;286(15):13612-25. doi: 10.1074/jbc.M110.216812. Epub 2011 Feb 14.

Supplemental Content

Loading ...
Support Center